Journal article : Comment
Balancing access to BPaLM regimens and risk of resistance
- Publication status:
- Published
- Peer review status:
- Reviewed (other)
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 41.1KB, Terms of use)
-
- Publisher copy:
- 10.1016/s1473-3099(22)00543-6
Authors
+ Wellcome Trust
More from this funder
- Funder identifier:
- https://ror.org/029chgv08
- Grant:
- 214560/Z/18/Z
+ European Commission
More from this funder
- Funder identifier:
- https://ror.org/00k4n6c32
- Grant:
- 101007873
+ Wetenschappelijk Onderzoek- en Documentatiecentrum
More from this funder
- Funder identifier:
- https://ror.org/0002exf56
- Publisher:
- Elsevier
- Journal:
- Lancet Infectious Diseases More from this journal
- Volume:
- 22
- Issue:
- 10
- Pages:
- 1411-1412
- Place of publication:
- United States
- Publication date:
- 2022-08-22
- Acceptance date:
- 2022-08-05
- DOI:
- EISSN:
-
1474-4457
- ISSN:
-
1473-3099
- Pmid:
-
36007529
- Language:
-
English
- Subtype:
-
Comment
- Pubs id:
-
1277238
- Local pid:
-
pubs:1277238
- Source identifiers:
-
W4293282409
- Deposit date:
-
2026-09-25
- ARK identifier:
Terms of use
- Copyright holder:
- Elsevier Ltd
- Copyright date:
- 2022
- Rights statement:
- © 2022 Elsevier Ltd. All rights reserved.
- Notes:
- This is the accepted manuscript version of the article. The final version is available online from Elsevier at https://dx.doi.org/10.1016/s1473-3099(22)00543-6
If you are the owner of this record, you can report an update to it here: Report update to this record